vinay prasad center for biologics evaluation and research - Search News

News

FDA names oncologist Vinay Prasad

Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies

Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was forced out.

CNN on MSN · 1d

FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.

FDA names Dr. Vinay Prasad as top vaccine official

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene therapies, and blood supply.

Axios on MSN1h

Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.

Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...

New CBER Director Vinay Prasad praises evidence, FDA reviewers in first speech to staff

WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...

BioPharma Dive1h

Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.

Across hundreds of published papers, CBER’s new chief has argued for more stringent measures of assessing drugs for cancer ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results